ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2060

Using the Electronic Medical Record to Increase Rates of Physician Assessment of Lipids in Patients with Systemic Lupus Erythematosus and Rheumatoid Arthritis: A Quality Improvement Initiative

Astrud Lorraine Leyva1, Laura L. Tarter1, Elizabeth Blair Solow2 and David R. Karp3, 1Division of Rheumatic Diseases, UT Southwestern Medical Center, Dallas, TX, 2Rheumatology, UT Southwestern Medical Center, Dallas, TX, 3Rheumatic Diseases Division, UT Southwestern Medical Center, Dallas, TX

Meeting: 2012 ACR/ARHP Annual Meeting

Keywords: quality of care

  • Tweet
  • Email
  • Print
Session Information

Title: Quality Measures and Innovations in Practice Management and Care Delivery

Session Type: Abstract Submissions (ACR)

Background/Purpose: Cardiovascular disease (CVD) is a major cause of morbidity and mortality in rheumatoid arthritis (RA) and systemic lupus erythematosus (SLE). Guidelines for the management of both SLE and RA recommend evaluation of and intervention for known cardiovascular risk factors, including dysplipidemia. However, studies suggest that screening rates remain suboptimal. Quality improvement methodology offers a practical approach to bridge this gap in care. The fellowship training setting is an ideal environment in which to pilot such a project, as the American College of Graduate Medical Education requires that fellows demonstrate the ability to continuously improve patient care. Our aim was to improve the rate of recording lipid panel results in patients with SLE or RA to over 50% in a one month period.

Methods: In our busy outpatient rheumatology clinic in a county hospital setting, we examined patient, provider, and health system factors that could be barriers to providing routine cardiovascular risk assessment for our patients. For our first Plan-Do-Act-Check (PDCA) cycle, we examined the frequency with which physicians recorded lipid panel results in clinic notes during routine visits. We obtained baseline data for all RA or SLE patient visits for each of our six clinical fellows one month period. Our hospital district utilizes the EPIC electronic medical record (EMR); thus we devised a simple “dotphrase” to assist providers in ascertaining the date and results of a patient’s most recent lipid panel with just a few keystrokes. We then organized an educational session for our providers to inform them about the initiative, the collective baseline data and applying the “dotphrase”.  Each clinical fellow also received an individual summary of their baseline screening rates. 

Results: We reviewed 91 patient visits during the pre-intervention period (69% RA, 31% SLE).  Patients were 46.7 years old (SD 14.7) and 83% female.  Forty-two percent of patients had a lipid panel sent within the past year. Lipid panels were ordered by primary care physicians (63%), rheumatologists (15%), and other physicians (22%). Twenty percent of patients were on statin therapy. Our providers documented lipid panel results, however, in only 12% of the visits. Following the implementation of the EMR “dotphrase”, we reviewed an additional 92 patient visits over a one month period. Baseline characteristics were similar to our pre-intervention group. Our providers augmented their lipid panel recording to a rate of 65% after the intervention.

Conclusion: In our hospital district setting with an integrated EMR, the use of a simple “dotphrase” was effective in improving provider documentation of lipid panel results in patients with RA and SLE.  Future PDCA cycles will focus on increasing rates of obtaining screening lipid panels and intervening in patients with documented dyslipidemia.


Disclosure:

A. L. Leyva,
None;

L. L. Tarter,
None;

E. B. Solow,
None;

D. R. Karp,
None.

  • Tweet
  • Email
  • Print

« Back to 2012 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/using-the-electronic-medical-record-to-increase-rates-of-physician-assessment-of-lipids-in-patients-with-systemic-lupus-erythematosus-and-rheumatoid-arthritis-a-quality-improvement-initiative/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology